Cargando…
High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer
Ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) has been identified as a potential biomarker in lung and prostate cancers; however, its expression and clinical relevance in hepatocellular carcinoma (HCC) remain incompletely understood. This study comprehensively assessed ENPP2 expression...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402965/ https://www.ncbi.nlm.nih.gov/pubmed/37543832 http://dx.doi.org/10.1097/MD.0000000000034480 |
_version_ | 1785084956886695936 |
---|---|
author | Meng, Jiyu Ruan, Xuelian Wei, Fangyi Xue, Qin |
author_facet | Meng, Jiyu Ruan, Xuelian Wei, Fangyi Xue, Qin |
author_sort | Meng, Jiyu |
collection | PubMed |
description | Ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) has been identified as a potential biomarker in lung and prostate cancers; however, its expression and clinical relevance in hepatocellular carcinoma (HCC) remain incompletely understood. This study comprehensively assessed ENPP2 expression in pan-cancer using bioinformatics. We analyzed the expression of ENPP2 mRNA in primary liver cancer and adjacent tissues of patients with HCC using data from the TCGA database. Cox regression and Kaplan–Meier methods were used to identify clinicopathological factors associated with survival, and the diagnostic value of ENPP2 expression was evaluated using receiver operating characteristic curve analysis. We also validated our findings by performing real-time PCR on clinical liver cancer samples. Furthermore, we conducted gene set enrichment analysis using the Cancer Genome Atlas dataset to gain additional insights into the biological significance of ENPP2 in HCC. High ENPP2 expression in HCC patients is associated with gender and clinical stage, and is a significant prognostic factor for worse outcomes. ENPP2 expression is an independent risk factor for progression-free and disease-specific survival in both cohorts, suggesting its potential as an HCC biomarker. ENPP2’s diagnostic value in HCC patients was confirmed by the area under the receiver operating characteristic curve, which was 0.806. real-time PCR analysis validated the higher expression of ENPP2 in clinical liver cancer tissues. Gene set enrichment analysis identified pathways enriched in HCC patients with high ENPP2 expression, including those related to the cell cycle, MTOR and T cell receptor signaling, and phosphatidylinositol signaling systems. We have demonstrated that ENPP2 is highly expressed in HCC and is a potential independent molecular marker for the diagnosis and prognosis of HCC. |
format | Online Article Text |
id | pubmed-10402965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104029652023-08-05 High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer Meng, Jiyu Ruan, Xuelian Wei, Fangyi Xue, Qin Medicine (Baltimore) 4500 Ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) has been identified as a potential biomarker in lung and prostate cancers; however, its expression and clinical relevance in hepatocellular carcinoma (HCC) remain incompletely understood. This study comprehensively assessed ENPP2 expression in pan-cancer using bioinformatics. We analyzed the expression of ENPP2 mRNA in primary liver cancer and adjacent tissues of patients with HCC using data from the TCGA database. Cox regression and Kaplan–Meier methods were used to identify clinicopathological factors associated with survival, and the diagnostic value of ENPP2 expression was evaluated using receiver operating characteristic curve analysis. We also validated our findings by performing real-time PCR on clinical liver cancer samples. Furthermore, we conducted gene set enrichment analysis using the Cancer Genome Atlas dataset to gain additional insights into the biological significance of ENPP2 in HCC. High ENPP2 expression in HCC patients is associated with gender and clinical stage, and is a significant prognostic factor for worse outcomes. ENPP2 expression is an independent risk factor for progression-free and disease-specific survival in both cohorts, suggesting its potential as an HCC biomarker. ENPP2’s diagnostic value in HCC patients was confirmed by the area under the receiver operating characteristic curve, which was 0.806. real-time PCR analysis validated the higher expression of ENPP2 in clinical liver cancer tissues. Gene set enrichment analysis identified pathways enriched in HCC patients with high ENPP2 expression, including those related to the cell cycle, MTOR and T cell receptor signaling, and phosphatidylinositol signaling systems. We have demonstrated that ENPP2 is highly expressed in HCC and is a potential independent molecular marker for the diagnosis and prognosis of HCC. Lippincott Williams & Wilkins 2023-08-04 /pmc/articles/PMC10402965/ /pubmed/37543832 http://dx.doi.org/10.1097/MD.0000000000034480 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | 4500 Meng, Jiyu Ruan, Xuelian Wei, Fangyi Xue, Qin High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer |
title | High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer |
title_full | High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer |
title_fullStr | High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer |
title_full_unstemmed | High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer |
title_short | High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer |
title_sort | high expression of enpp2 is an independent predictor of poor prognosis in liver cancer |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402965/ https://www.ncbi.nlm.nih.gov/pubmed/37543832 http://dx.doi.org/10.1097/MD.0000000000034480 |
work_keys_str_mv | AT mengjiyu highexpressionofenpp2isanindependentpredictorofpoorprognosisinlivercancer AT ruanxuelian highexpressionofenpp2isanindependentpredictorofpoorprognosisinlivercancer AT weifangyi highexpressionofenpp2isanindependentpredictorofpoorprognosisinlivercancer AT xueqin highexpressionofenpp2isanindependentpredictorofpoorprognosisinlivercancer |